Filter News
Area of Research
- (-) Isotopes (2)
- (-) Nuclear Science and Technology (3)
- Advanced Manufacturing (2)
- Biology and Environment (15)
- Clean Energy (22)
- Computational Biology (1)
- Computational Engineering (3)
- Computer Science (5)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion Energy (1)
- Materials (13)
- Materials for Computing (3)
- Mathematics (1)
- National Security (16)
- Neutron Science (10)
- Quantum information Science (2)
- Supercomputing (46)
News Type
News Topics
- (-) Biomedical (4)
- (-) Cybersecurity (1)
- 3-D Printing/Advanced Manufacturing (2)
- Advanced Reactors (7)
- Bioenergy (1)
- Climate Change (1)
- Computer Science (2)
- Decarbonization (1)
- Energy Storage (1)
- Environment (2)
- Fusion (2)
- Irradiation (1)
- Isotopes (13)
- Materials (2)
- Materials Science (2)
- Molten Salt (3)
- Neutron Science (4)
- Nuclear Energy (20)
- Physics (1)
- Security (1)
- Space Exploration (6)
- Sustainable Energy (1)
- Transformational Challenge Reactor (1)
Media Contacts
Researchers at ORNL explored radium’s chemistry to advance cancer treatments using ionizing radiation.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
Two staff members at the Department of Energy’s Oak Ridge National Laboratory have received prestigious HENAAC and Luminary Awards from Great Minds in STEM, a nonprofit organization that focuses on promoting STEM careers in underserved
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.